Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression

Human Pathology

Volumn 29, Issue 6, 1998, Pages 551-558

  Lax, S F ^a   Pizer, E S ^a   Ronnett, B M ^a   Kurman, R J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Clear cell carcinoma; Endometrial carcinogenesis; Endometrial carcinoma; Endometrium; Immunohistochemistry

Indexed keywords

ESTROGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLEAR CELL CARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY;

EID: 0031746796     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)80002-6     Document Type: Article

References (26)

1. Bokhman JV Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
2. Sherman ME Bur ME Kurman RJ p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis Hum Pathol 26 1995 1268 1274
3. Ambros RA Sherman ME Zahn CM Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation Hum Pathol 26 1995 1260 1267
4. Tashiro H Isacson C Levine R p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis Am J Pathol 150 1997 177 185
5. Kohler MF Berchuck A Davidoff AM Overexpression and mutation of p53 in endometrial carcinoma Cancer Res 52 1992 1622 1627
6. Abeler VM Kjorstad KE Endometrial adenocarcinoma in Norway: A study of a total population Cancer 67 1991 3093 3103
7. Abeler VM Kjorstad KE Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 cases Gynecol Oncol 40 1991 207 217
8. Carcangiu ML Chambers JT Voynick IM Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations Am J Clin Pathol 94 1990 247 254
9. [published erratum appears in Int J Gynecol Pathol 1996 Oct; 15(4):369] Yamauchi N Sakamoto A Uozaki H Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity Int J Gynecol Pathol 15 1996 202 208
10. Reinartz JJ George E Lindgren BR Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival Hum Pathol 25 1994 1075 1083
11. Khalifa MA Mannel RS Haraway SD Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas Gynecol Oncol 53 1994 84 92
12. Scully RE Bonfiglio TA Kurman RJ Histopathological typing of the female genital tract tumours Sobin L World Health Organization International Histological Classification of Tumours (ed 2) 1994 Springer Verlag Berlin, Germany
13. Young RH Scully RE Oxyphilic clear cell carcinoma of the ovary: A report of nine cases Am J Surg Pathol 11 1987 661 667
14. Lax SF, Pizer ES, Ronnett BM, et al: Comparison of estrogen and progesterone receptor, ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol (in press)
15. Sherman ME Bitterman P Rosenshein NB Uterine serous carcinoma: A morphologically diverse neoplasm with unifying clinicopathological features Am J Surg Pathol 16 1992 600 610
16. Remmele W Schicketanz KH Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer: Computer-assisted image analysis (QIC score) vs. subjective grading (IRS) Pathol Res Pract 189 1993 862 866
17. Shepherd NA Richman PI England J Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations J Pathol 155 1988 213 219
18. Hendrickson M Ross J Eifel P Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma Am J Surg Pathol 6 1982 93 108
19. Kurman RJ Zaino RJ Norris HJ Endometrial carcinoma Kurman RJ Blaustein's Pathology of the Female Genital Tract (ed 4) 1994 Springer-Verlag New York, NY 439 486
20. Carcangiu ML Chambers JT Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: Comparison of clinicopathologic features and survival Int J Gynecol Pathol 14 1995 30 38
21. Sasano H Comerford J Wilkinson DS Serous papillary adenocarcinoma of the endometrium: Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors and immunohistochemistry Cancer 65 1990 1545 1551
22. Sorbe B Risberg B Frankendal B DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma Gynecol Oncol 38 1990 22 27
23. Rosenberg P Wingren S Simonsen E Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicator Gynecol Oncol 35 1989 50 54
24. Nordstrom B Strang P Bergstrom R A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma: Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction Cancer 78 1996 1942 1951
25. Pitman MB Young RH Clement PB Endometrioid carcinoma of the ovary and endometrium, oxyphilic cell type: A report of nine cases Int J Gynecol Pathol 13 1994 290 301
26. Carcangiu ML Sibley RK Rosai J Clear cell change in primary thyroid tumors: A study of 38 cases Am J Surg Pathol 9 1985 705 722